Cargando…
Combinatorial RNA Interference Therapy Prevents Selection of Pre-existing HBV Variants in Human Liver Chimeric Mice
Selection of escape mutants with mutations within the target sequence could abolish the antiviral RNA interference activity. Here, we investigated the impact of a pre-existing shRNA-resistant HBV variant on the efficacy of shRNA therapy. We previously identified a highly potent shRNA, S1, which, whe...
Autores principales: | Shih, Yao-Ming, Sun, Cheng-Pu, Chou, Hui-Hsien, Wu, Tzu-Hui, Chen, Chun-Chi, Wu, Ping-Yi, Enya Chen, Yu-Chen, Bissig, Karl-Dimiter, Tao, Mi-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612501/ https://www.ncbi.nlm.nih.gov/pubmed/26482836 http://dx.doi.org/10.1038/srep15259 |
Ejemplares similares
-
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy
por: Kruse, Robert L., et al.
Publicado: (2017) -
CTLA-4 interferes with the HBV-specific T cell immune response (Review)
por: Cao, Hui, et al.
Publicado: (2018) -
A human liver chimeric mouse model for non-alcoholic fatty liver disease
por: Bissig-Choisat, Beatrice, et al.
Publicado: (2021) -
Shared probe design and existing microarray reanalysis using PICKY
por: Chou, Hui-Hsien
Publicado: (2010) -
A direct comparison of strategies for combinatorial RNA interference
por: Lambeth, Luke S, et al.
Publicado: (2010)